The FDA is pressing ahead with national licensure standards for wholesale distributors and third-party logistics providers, raising urgent questions across the pharmaceutical supply chain.
At the heart of the debate is whether a federal baseline will genuinely reduce compliance burdens or simply introduce another layer of regulation on top of existing state requirements.
Kala Shankle, vice president of regulatory affairs at the Healthcare Distribution Alliance, is among the industry voices helping to frame what this transition actually means in practice.
Shankle is set to appear on a panel at HDA’s 2026 Traceability Seminar titled “Beyond Traceability: Preparing for National Licensure Standards,” where these questions will be examined in depth.
The session is expected to explore the operational, quality, and compliance implications of a standardised licensure framework, as well as the evolving role of state boards of pharmacy in the process.
Currently, distributors and 3PLs must maintain compliance infrastructure capable of tracking renewal cycles, inspections, and designated representatives across every state in which they operate.
That state-by-state patchwork creates significant administrative overhead, requiring companies to monitor varying requirements, timelines, and enforcement expectations simultaneously.
Shankle frames the central question plainly: how much variation will states still be permitted to layer on top of a federal baseline once national standards are formally in place.
If states retain the ability to impose significant additional requirements alongside the new federal standard, companies may find themselves building more compliance frameworks rather than consolidating existing ones.
Her assessment sets up a broader theme, namely that the value of national licensure depends less on the standard itself than on how consistently it is implemented across jurisdictions.
For the wholesale distribution and 3PL sectors, the outcome of that implementation question carries real operational consequences, affecting staffing, systems, and long-term compliance strategy.
The HDA has been a central voice in pushing for clarity on how federal and state authority will interact under any new standardised framework going forward.